Horstem
Item No. 90804
Horstem is the 1st licenced veterinary medicine composed of mesenchymal umbilical cord stem cells which is authorised by the European Medicines Agency. -Injectable suspension for intraarticular use in horses -15 Million equine umbilical cord mesenchymal stem cells per dose -It has been specially
Description
Horstem is the 1st licenced veterinary medicine composed of mesenchymal umbilical cord stem cells which is authorised by the European Medicines Agency.
-Injectable suspension for intraarticular use in horses
-15 Million equine umbilical cord mesenchymal stem cells per dose
-It has been specially developed in a “ready to use” format that allows its easy and safe injection under field conditions without the need for handling and/or thawing by the veterinarian.
Indication:
Reduction of lameness associated with mild to moderate degenerative joint disease (osteoarthritis)
-Injectable suspension for intraarticular use in horses
-15 Million equine umbilical cord mesenchymal stem cells per dose
-It has been specially developed in a “ready to use” format that allows its easy and safe injection under field conditions without the need for handling and/or thawing by the veterinarian.
Indication:
Reduction of lameness associated with mild to moderate degenerative joint disease (osteoarthritis)
Specifications
- Business Unit
- Equine
- Legal category
- POM
Horstem
Item No. 90804
Horstem is the 1st licenced veterinary medicine composed of mesenchymal umbilical cord stem cells which is authorised by the European Medicines Agency. -Injectable suspension for intraarticular use in horses -15 Million equine umbilical cord mesenchymal stem cells per dose -It has been specially
Description
Horstem is the 1st licenced veterinary medicine composed of mesenchymal umbilical cord stem cells which is authorised by the European Medicines Agency.
-Injectable suspension for intraarticular use in horses
-15 Million equine umbilical cord mesenchymal stem cells per dose
-It has been specially developed in a “ready to use” format that allows its easy and safe injection under field conditions without the need for handling and/or thawing by the veterinarian.
Indication:
Reduction of lameness associated with mild to moderate degenerative joint disease (osteoarthritis)
-Injectable suspension for intraarticular use in horses
-15 Million equine umbilical cord mesenchymal stem cells per dose
-It has been specially developed in a “ready to use” format that allows its easy and safe injection under field conditions without the need for handling and/or thawing by the veterinarian.
Indication:
Reduction of lameness associated with mild to moderate degenerative joint disease (osteoarthritis)
Specifications
- Business Unit
- Equine
- Legal category
- POM
